These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25621464)

  • 1. Recurrent Thyroid Eye Disease.
    Patel P; Khandji J; Kazim M
    Ophthalmic Plast Reconstr Surg; 2015; 31(6):445-8. PubMed ID: 25621464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid eye disease: a Southeast Asian experience.
    Lim NC; Sundar G; Amrith S; Lee KO
    Br J Ophthalmol; 2015 Apr; 99(4):512-8. PubMed ID: 25361748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of Graves' orbitopathy after rehabilitative orbital decompression.
    Baldeschi L; Lupetti A; Vu P; Wakelkamp IM; Prummel MF; Wiersinga WM
    Ophthalmology; 2007 Jul; 114(7):1395-402. PubMed ID: 17320178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.
    Mellington FE; Dayan CM; Dickinson AJ; Hickey JL; MacEwen CJ; McLaren J; Perros P; Rose GE; Uddin J; Vaidya B; Foley P; Lazarus JH; Mitchell A; Ezra DG;
    Orbit; 2017 Jun; 36(3):159-169. PubMed ID: 28296512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid-Related Orbital Decompression Surgery: A Multivariate Analysis of Risk Factors and Outcomes.
    Wu CY; Niziol LM; Musch DC; Kahana A
    Ophthalmic Plast Reconstr Surg; 2017; 33(3):189-195. PubMed ID: 27097064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose orbital radiotherapy for thyroid eye disease.
    Li Yim JF; Sandinha T; Kerr JM; Ritchie D; Kemp EG
    Orbit; 2011 Dec; 30(6):269-74. PubMed ID: 22132844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy.
    Sisti E; Menconi F; Leo M; Profilo MA; Mautone T; Mazzi B; Rocchi R; Latrofa F; Nardi M; Vitti P; Marcocci C; Marinò M
    J Endocrinol Invest; 2015 Jun; 38(6):661-8. PubMed ID: 25596664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' Ophthalmopathy in a Paediatric Population.
    Sadeghi Y; Obéric A; Theintz G; Hamédani M
    Klin Monbl Augenheilkd; 2017 Apr; 234(4):591-594. PubMed ID: 28329893
    [No Abstract]   [Full Text] [Related]  

  • 9. Natural history of graves' orbitopathy after treatment.
    Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M
    Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid eye disease: a review.
    Weiler DL
    Clin Exp Optom; 2017 Jan; 100(1):20-25. PubMed ID: 27701774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.
    Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ
    Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postural visual obscurations in patients with inactive thyroid eye disease; a variant of 'hydraulic' disease.
    Rose GE
    Eye (Lond); 2006 Oct; 20(10):1178-85. PubMed ID: 17019416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age differences in clinical manifestation and prognosis of thyroid eye disease.
    Ben Simon GJ; Katz G; Zloto O; Leiba H; Hadas B; Huna-Baron R
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2301-8. PubMed ID: 26344731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late reactivation of thyroid orbitopathy.
    Selva D; Chen C; King G
    Clin Exp Ophthalmol; 2004 Feb; 32(1):46-50. PubMed ID: 14746591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking and strabismus surgery in patients with thyroid eye disease.
    Rajendram R; Bunce C; Adams GG; Dayan CM; Rose GE
    Ophthalmology; 2011 Dec; 118(12):2493-7. PubMed ID: 21872937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A treatment strategy for Graves' orbitopathy.
    Marcocci C; Pinchera A; Marinò M
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):430-6. PubMed ID: 17452970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
    Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of difficult endocrine orbitopathy cases].
    Breuer T; Ammann-Rauch D; Tasman AJ
    Laryngorhinootologie; 2007 May; 86(5):376-81. PubMed ID: 17252323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral optic nerve edema presenting as initial manifestation of thyroid eye disease.
    Wilson ME; Kim C; Carrasco J
    Orbit; 2016 Oct; 35(5):288-91. PubMed ID: 27486810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of strabismus in thyroid eye disease.
    Harrad R
    Eye (Lond); 2015 Feb; 29(2):234-7. PubMed ID: 25523204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.